Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 4106-4114

  Lu, Chunyan ^a,b   Ivaska, Kaisa K ^c   Alen, Markku ^d   Wang, Qingju ^e   Tor̈mäkangas, Timo ^b   Xu, Leiting ^b   Wiklund, Petri ^b   Mikkola, Tuija M ^b   Pekkala, Satu ^b   Tian, Haoming ^a   Väänänen, H Kalervo ^c   Cheng, Sulin ^b,f  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f SHANGHAI UNIVERSITY OF SPORT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CORTICOSTEROID; GLUCOCORTICOID; GLUCOSE; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEPTIN; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLERGY; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG USE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRANDPARENT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MOTHER; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPONECTIN; ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; BONE AND BONES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MIDDLE AGED; OSTEOCALCIN; PREMENOPAUSE;

EID: 84867682449     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2045     Document Type: Article

References (62)

1. Fukumoto S, Martin TJ 2009 Bone as an endocrine organ. Trends Endocrinol Metab 20:230-236
2. Lee NK, Karsenty G 2008 Reciprocal regulation of bone and energy metabolism. J Musculoskelet Neuronal Interact 8:351
3. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G 2010 Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142:296-308
4. Fulzele K, Riddle RC, DiGirolamo DJ, Cao X, Wan C, Chen D, Faugere MC, Aja S, Hussain MA, Brüning JC, Clemens TL 2010 Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142:309-319
5. Karsenty G, Oury F 2010 The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J Clin Endocrinol Metab 95:4795-4801
6. Karsenty G, Ferron M 2012 The contribution of bone to whole-organism physiology. Nature 481:314-320
7. Ducy P 2011 The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54:1291-1297
8. Pi M, Wu Y, Quarles LD 2011 GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo. J Bone Miner Res 26:1680-1683
9. Ferron M, Hinoi E, Karsenty G, Ducy P 2008 Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266-5270 (Pubitemid 351738545)
10. Dowd TL, Rosen JF, Li L, Gundberg CM 2003 The three-dimensional structure of bovine calcium ion-bound osteocalcin using 1H NMR spectroscopy. Biochemistry 42:7769-7779 (Pubitemid 36758942)
11. Hoang QQ, Sicheri F, Howard AJ, Yang DS 2003 Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425:977-980 (Pubitemid 37376930)
12. Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK 2004 Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 279:18361-18369 (Pubitemid 38623251)
13. Gundberg CM, Nieman SD, Abrams S, Rosen H 1998 Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 83:3258-3266 (Pubitemid 28500970)
14. Shea MK, Gundberg CM, Meigs JB, Dallal GE, Saltzman E, Yoshida M, Jacques PF, Booth SL 2009 Gamma-carboxylation of osteocalcin and insulin resistance in older men and women. Am J Clin Nutr 90:1230-1235
15. Knapen MH, Schurgers LJ, Shearer MJ, Newman P, Theuwissen E, Vermeer C 2011 Association of vitamin K status with adiponectin and body composition in healthy subjects: uncarboxylated osteocalcin is not associated with fat mass and body weight. Br J Nutr 1-8
16. Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N 2012 Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int 23:761-770
17. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469 (Pubitemid 47208519)
18. Karsenty G 2008 Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9:183-196
19. Confavreux CB, Levine RL, Karsenty G 2009 A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 310:21-29
20. Ng KW 2011 Regulation of glucose metabolism and the skeleton. Clin Endocrinol (Oxf) 75:147-155
21. Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R 2008 Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57:980-986
22. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N 2006 Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91:3873-3877 (Pubitemid 44536857)
23. Gravenstein KS, Napora JK, Short RG, Ramachandran R, Carlson OD, Metter EJ, Ferrucci L, Egan JM, Chia CW 2011 Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. J Clin Endocrinol Metab 96:E884-E890
24. Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U, Mellström D 2009 Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res 24:785-791
25. Motyl KJ, McCabe LR, Schwartz AV 2010 Bone and glucose metabolism: a two-way street. Arch Biochem Biophys 503:2-10
26. McCabe LR 2007 Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102:1343-1357 (Pubitemid 350223938)
27. Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishimura E, Nakatsuka K, Shioi A, Morii H 1999 Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9:525-531 (Pubitemid 29348568)
28. Im JA, Yu BP, Jeon JY, Kim SH 2008 Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 396:66-69
29. Kanazawa I, Yamaguchi T, Tada Y, Yamauchi M, Yano S, Sugimoto T 2011 Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone 48:720-725
30. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T 2011 Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22:187-194
31. Hwang YC, Jeong IK, Ahn KJ, Chung HY 2009 The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced β-cell function in middle-aged male subjects. Diabetes Metab Res Rev 25:768-772
32. Hwang YC, Jeong IK, Ahn KJ, Chung HY 2012 Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int 23:1337-1342
33. Reinehr T, Roth CL 2010 A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond) 34:852-858
34. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-349 (Pubitemid 26076383)
35. Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K 2004 Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 47:185-193 (Pubitemid 38270396)
36. Wu XY, Wu XP, Xie H, Zhang H, Peng YQ, Yuan LQ, Su X, Luo XH, Liao EY 2010 Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationshipamong Chinese adult women. Osteoporos Int 21:275-285
37. Atalay S, Elci A, Kayadibi H, Onder CB, Aka N 2012 Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med 32:23-30
38. Cheng S, Völgyi E, Tylavsky FA, Lyytikäinen A, Törmakängas T, XuL, Cheng SM, Kröger H, Alèn M, Kujala UM 2009 Trait-specific tracking and determinants of body composition: a 7-year follow-up study of pubertal growth in girls. BMC Med 7:5
39. Käkonen SM, Hellman J, Karp M, Laaksonen P, Obrant KJ, Väänänen HK, Lövgren T, Pettersson K 2000 Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum. Clin Chem 46:332-337
40. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
41. Tenerz A, Norhammar A, Silveira A, Hamsten A, Nilsson G, Rydén L, Malmberg K 2003 Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes. Diabetes Care 26:2770-2776 (Pubitemid 37205545)
42. Timonen M, Salmenkaita I, Jokelainen J, Laakso M, Härkönen P, Koskela P, Meyer-Rochow VB, Peitso A, Keinänen-Kiukaanniemi S 2007 Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psychosom Med 69:723-728 (Pubitemid 350287478)
43. Hardin JW, Hilbe J 2003 Generalized estimating equations. Boca Raton, FL: Chapman & Hall
44. Natarajan S, Lipsitz SR, Rimm E 2007 A simple method of determining confidence intervals for population attributable risk from complex surveys. Stat Med 26:3229-3239 (Pubitemid 47039783)
45. Seeman E 2002 Pathogenesis of bone fragility in women and men. Lancet 359:1841-1850 (Pubitemid 34607063)
46. Chandler-Laney PC, Phadke RP, Granger WM, Fernández JR, Muñoz JA, Man CD, Cobelli C, Ovalle F, Gower BA Age-related changes in insulin sensitivity and β-cell function among European-American and African-American women. Obesity (Silver Spring) 19:528-535
47. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, Liu K, Ouyang P 2007 Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab 92:1289-1295 (Pubitemid 46556400)
48. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, Gapstur SM, Golden SH 2009 The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab 94:4127-4135
49. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197-207 (Pubitemid 30064908)
50. Elefteriou F, Ahn JD, Takeda S, Starbuck M, Yang X, Liu X, Kondo H, Richards WG, Bannon TW, Noda M, Clement K, Vaisse C, Karsenty G 2005 Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434:514-520 (Pubitemid 40477060)
51. Bartell SM, Rayalam S, Ambati S, Gaddam DR, Hartzell DL, Hamrick M, She JX, Della-Fera MA, Baile CA 2011 Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptindeficient ob/ob mice. J Bone Miner Res 26:1710-1720
52. Hinoi E, Gao N, Jung DY, Yadav V, Yoshizawa T, Myers Jr MG, Chua Jr SC, Kim JK, Kaestner KH, Karsenty G 2008 The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J Cell Biol 183:1235-1242
53. Karsenty G 2006 Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab 4:341-348 (Pubitemid 44645074)
54. Yadav VK, Karsenty G 2009 Leptin-dependent co-regulation of bone and energy metabolism. Aging (Albany NY) 1:954-956
55. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G 2012 Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50:568-575
56. Kumar R, Vella A 2011 Carbohydrate metabolism and the skeleton: picking a bone with the β-cell. J Clin Endocrinol Metab 96:1269-1271
57. Bulló M, Moreno-Navarrete JM, Fernández-Real JM, Salas-Salvadó J 2012 Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk. Am J Clin Nutr 95:249-255
58. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B 2009 Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 94:827-832
59. Gravenstein KS, Napora JK, Short RG, Ramachandran R, Carlson OD, Metter EJ, Ferrucci L, Egan JM, Chia CW 2011 Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. J Clin Endocrinol Metab 96:E884-E890
60. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG 1990 Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228 (Pubitemid 20034509)
61. Højlund K, Beck-Nielsen H 2006 Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes? Curr Diabetes Rev 2:375-395 (Pubitemid 44734226)
62. Vind BF, Birk JB, Vienberg SG, Andersen B, Beck-Nielsen H, Wojtaszewski JF, Højlund K 2012 Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes. Diabetologia 55:1435-1445